Flow Contract Site Laboratory, LLC is a specialized contract research organization (CRO) that provides non-GLP and GLP flow cytometry services for research, nonclinical, and clinical drug development. Their capabilities include up to 8-color antibody panels for immunophenotyping, receptor occupancy, intracellular cytokine and phospho-protein detection, cell cycle arrest and progression, antigen stability, and cellular functional assays. In addition, they offer bead-based assays for excreted cytokine detection and HLA antibodies. Proficient in processing various specimen types including whole blood, tissue, frozen PBMCs, and tumors, they cater to pre-clinical model systems and human clinical trials. Founded in 2009, the company operates in the Biotechnology and Health Care industries and focuses on providing Personalized Flow Cytometry Services. Currently, there is no publicly available information regarding their headquarter, last investment, or investors.
There is no investment information
No recent news or press coverage available for Flow Contract Site Laboratory, LLC.